Summary
Removes the rule that new Medicaid test programs cannot cost more than existing programs, allowing for more flexible and innovative healthcare projects.
What problem does this solve?
Current rules may prevent new, helpful Medicaid programs from starting if they have higher upfront costs. This bill removes the rule that requires these new programs to be cost-neutral, encouraging innovation in healthcare for Medicaid patients.
Who does this affect?
- State governments
- Medicaid recipients
- Healthcare providers
What does this bill do?
Reference
Text:
Section:
Sec. 2(a)
Header:
Repealing budget neutrality requirement for certain medicaid demonstration projects
Repeals budget neutrality rule
Eliminates the requirement from Public Law 119-21 that certain new Medicaid test projects must not increase federal spending.
Takes back previously approved funds
Cancels any money that was set aside under the now-repealed section of Public Law 119-21.
Reference
Text:
Section:
Sec. 2(a)
Header:
Repealing budget neutrality requirement for certain medicaid demonstration projects
Restores prior law
Makes it so that Section 1115 of the Social Security Act is applied as it was before the budget neutrality rule was created.
What is the real world impact?
•
Encourages healthcare innovation
Allows states to test new Medicaid programs that could improve health outcomes, even if they cost more at the start. The goal is to find better ways to provide care that might save money or lives in the long run.
•
Increases federal spending on healthcare
Removes a key spending control on new Medicaid projects. This could lead to states proposing expensive new programs without a guarantee that they will be effective or save money later, increasing the federal budget.
When does this start?
The changes would take effect as soon as the bill is signed into law.